The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

This study reports preclinical data showing that the interleukin (IL)-1β modulation is a new promising target in the pathophysiological context of heart failure. Indeed, in nondiabetic Wistar and diabetic Goto-Kakizaki rats with chronic heart failure induced by myocardial infarction, administration...

詳細記述

保存先:
書誌詳細
出版年:JACC Basic Transl Sci
主要な著者: Harouki, Najah, Nicol, Lionel, Remy-Jouet, Isabelle, Henry, Jean-Paul, Dumesnil, Anais, Lejeune, Annie, Renet, Sylvanie, Golding, Francesca, Djerada, Zoubir, Wecker, Didier, Bolduc, Virginie, Bouly, Muriel, Roussel, Jerome, Richard, Vincent, Mulder, Paul
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2017
主題:
MINI-FOCUS: INFLAMMATION IN CARDIAC INJURY
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034492/
https://ncbi.nlm.nih.gov/pubmed/30062160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.06.005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料